Proteorex Therapeutics Inc. wins recognition at BioPharm America™

16 Sep 2015 Proteorex News

Toronto-based biotech startup wins recognition at BioPharm America™ 2015 during Johnson & Johnson Innovation Startup Day competition

Wednesday, September 23, 2015

CARLSBAD, Calif. and BOSTON, Sept. 16, 2015 /PRNewswire/ — EBD Group today announced the winners of the first annual Johnson & Johnson Innovation Biotech Startup Day competition at the eighth annual BioPharm America™ 2015 life science partnering event in Boston.

The winner of the Johnson & Johnson Innovation Startup Day competition grand prize went to Proteorex Therapeutics Inc. for their innovative technology and services to support drug discovery. As the grand prize winner of the competition Proteorex Therapeutics Inc. will have the opportunity to gain access to the use of one bench at a Johnson & Johnson Innovation, JLABS location for three months and six months of mentorship from a Johnson & Johnson Innovation team member.

Cardiio, Inc. based in Cambridge, MA, was chosen from among 20 pre-selected startups who participated in an open mic pitch contest at Biotech Startup Day. Participants pitched to a judging panel of industry experts made up of top investors, including from Johnson & Johnson Innovation, Mass Med Angels and Boston Harbor Angels, Teva Pharmaceuticals, Atlas Venture, and Lilly Ventures. Cardiio, Inc. will receive a presentation slot at, and complimentary full access registration to, the 2016 BioPharm America event from the EBD Group.

This year was the first edition of Biotech Startup Day, a dedicated day at BioPharm America specifically designed to provide early-stage projects and young companies the opportunity to get on the radar of the global life science community.

View Original Article: http://www.prnewswire.com/news-releases/best-of-boston-biotech-startups-win-recognition-at-biopharm-america-2015-during-johnson–johnson-innovation-startup-day-competition-300144515.html

Search

+